Pharm-Rx Doxylamine Succinate
- CAS Number
- 562-10-7
- Chemical Name
- Doxylamine Succinate
- Molecular Formula
- C₂₁H₂₈N₂O₅, C₁₇H₂₂N₂O · C₄H₆O₄
Pharm-Rx Doxylamine Succinate, identified by the chemical name doxylamine succinate, is a prominent active pharmaceutical ingredient (API) within the realm of pharmaceuticals and nutraceuticals. It plays a significant role in the healthcare and pharma markets. With versatile applications, this product contributes to drug delivery and care solutions, aligning with various other drug and care solutions available in the market.
Properties
- Physical Form
- Powder
Product families
Applications
- Other Drug & Care Solutions
Product Families
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Chemical Inventories
AICS (Australia), DSL (Canada), ECL (Korea), EINECS (EU), TCSI (Taiwan); AICS (Australia); DSL (Canada); ECL (Korea); EINECS (EU); TCSI (Taiwan)
- Certifications & Compliance
California Proposition 65, DMF Type II, FDA 29 CFR 1910.1200
- Markets
- Healthcare & Pharma
- Definition
Doxylamine Succinate contains not less than 98.0% and not more than 102.0% of doxylamine succinate (C₁₇H₂₂N₂O · C₄H₆O₄), calculated on the dried basis.
- Soluble In
- Alcohol Soluble
- Chloroform Soluble
- Water Soluble
- Technology
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- USP Reference Standards
USP Carbinoxamine Related Compound C RS N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1- amine; Desmethyl doxylamine. C16H20N2O 256.35 (USP 1-May-2019) USP Doxylamine Succinate RS
- Certifications and Compliance
- California Proposition 65
- DMF Type II
- FDA 29 CFR 1910.1200
Technical data
Table 1 of 1
1 row| Characteristic | Value |
|---|---|
| Molecular Weight | 388.5 |
